Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells (original) (raw)
Enhanced doxorubicin transport to multidrug resistant breast cancer cells via TiO2 nanocarriers
Narayan Hosmane
RSC Advances, 2013
View PDFchevron_right
Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
zar chi soe
Pharmaceutics, 2019
View PDFchevron_right
Environmentally responsive dual-targeting nanoparticles: improving drug accumulation in cancer cells as a way of preventing anticancer drug efflux
cenk daglioglu
Journal of pharmaceutical sciences, 2017
View PDFchevron_right
Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicin
Manu Smriti Singh
International journal of pharmaceutics, 2015
View PDFchevron_right
Study on Doxorubicin Loading on Differently Functionalized Iron Oxide Nanoparticles: Implications for Controlled Drug-Delivery Application
gennady gennady
International Journal of Molecular Sciences
View PDFchevron_right
Galactoxyloglucan-Modified Nanocarriers of Doxorubicin for Improved Tumor-Targeted Drug Delivery with Minimal Toxicity
Mini Saraswathy, Manu Joseph, Sreelekha Tt
Journal of Biomedical Nanotechnology, 2014
View PDFchevron_right
Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-Mediated drug resistance
Ralf Morgenstern
Biomaterials, 2014
View PDFchevron_right
Transferrin targeted core-shell nanomedicine for combinatorial delivery of doxorubicin and sorafenib against hepatocellular carcinoma
Shantikumar Nair
Nanomedicine: Nanotechnology, Biology and Medicine, 2014
View PDFchevron_right
Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness
Veronica Morea
Journal of Controlled Release, 2016
View PDFchevron_right
Comparison of Doxorubicin Anticancer Drug Loading on Different Metal Oxide Nanoparticles
Salamat Ali
Medicine, 2015
View PDFchevron_right
Enhanced cytotoxicity and nuclear accumulation of doxorubicin-loaded nanospheres in human breast cancer MCF7 cells expressing MRP1
Bruno GIROUX
International Journal of Oncology, 2003
View PDFchevron_right
H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection
Kelong Fan
View PDFchevron_right
Enhanced tumor uptake and activity of nanoplex-loaded doxorubicin
James Mixson
Biochemical and Biophysical Research Communications, 2019
View PDFchevron_right
Enhancement effect of nano Fe3O4 to the drug accumulation of doxorubicin in cancer cells
Renyun Zhang
Materials Science and Engineering: C, 2009
View PDFchevron_right
Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity
Igor Chourpa
Journal of Nanoparticle Research, 2010
View PDFchevron_right
Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells
Asim Abdel-Mageed
Scientific Reports, 2016
View PDFchevron_right
Transferrin-conjugated doxorubicin-loaded PLGA nanoparticles with pH-responsive behavior: a synergistic approach for cancer therapy
CLARICE MADALENA BUENO ROLIM
Journal of Nanoparticle Research, 2020
View PDFchevron_right
Role of Surface Chemistry in Mediating the Uptake of Ultrasmall Iron Oxide Nanoparticles by Cancer Cells
Yuping Bao
ACS Applied Materials & Interfaces, 2019
View PDFchevron_right
Doxorubicin‐Conjugated Iron Oxide Nanoparticles: Surface Engineering and Biomedical Investigation
Iulia Lungu
ChemPlusChem, 2020
View PDFchevron_right
Nanoceria-mediated delivery of doxorubicin enhances the anti-tumour efficiency in ovarian cancer cells via apoptosis
Musa Reza
Scientific Reports, 2017
View PDFchevron_right
Dextran-Based Doxorubicin Nanocarriers with Improved Tumor Penetration
Hiển Dũng Dương
Biomacromolecules, 2014
View PDFchevron_right
The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages
Stefan Silver
Nano letters, 2016
View PDFchevron_right
SPIONs Conjugate Supported Anticancer Drug Doxorubicin’s Delivery: Current Status, Challenges, and Prospects
Ghassan M . Sulaiman
Nanomaterials
View PDFchevron_right
Magnetic Driven Nanocarriers for pH-Responsive Doxorubicin Release in Cancer Therapy
Fátima Martel
Molecules, 2020
View PDFchevron_right
Nanoparticle-Mediated Drug Delivery of Doxorubicin Induces a Differentiated Clonogenic Inactivation in 3D Tumor Spheroids In Vitro
Iulia Savu
International Journal of Molecular Sciences
View PDFchevron_right
Send Orders for Reprints to reprints@benthamscience.ae In Vitro Study on the Effect of Nanoparticles and Transfersomes as Targeted Drug Carrier for Cancer
KARTHIKEYAN M
View PDFchevron_right
Advances in nano delivery systems for doxorubicin an updated insight.pdf
Muhammad Ovais
View PDFchevron_right
Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms
Romila Manchanda
Nanomedicine: Nanotechnology, Biology and Medicine, 2011
View PDFchevron_right
Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models
Erez Koren
Cancer Biology & Therapy, 2014
View PDFchevron_right
Study of the Cytotoxicity Effect of Doxorubicin-loaded/Folic acid-Targeted Super Paramagnetic Iron Oxide Nanoparticles on AGS Cancer Cell Line
asadollah asadi
Journal of Nanomedicine & Nanotechnology, 2016
View PDFchevron_right
Bio-Responsive Carriers for Controlled Delivery of Doxorubicin to Cancer Cells
Marieta Constantin
Pharmaceutics
View PDFchevron_right